Read + Share
Amedeo Smart
Independent Medical Education
Cay S, Kara M, Ozcan F, Ozeke O, et al. Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol 2022 Apr 2. pii: 10.1007/s10840-022-01186.PMID: 35366133
Email
LinkedIn
Facebook
Twitter
Privacy Policy